1448661
Moxifloxacin Related Compound F
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 1179992-99-4
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 1448661-25-MG | In Stock | ₹ 1,30,159.80 |
1448661 - 25 MG
In Stock
Quantity
1
Base Price: ₹ 1,30,159.80
GST (18%): ₹ 23,428.764
Total Price: ₹ 1,53,588.564
grade
pharmaceutical primary standard
API family
moxifloxacin
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Sigma Aldrich Fine Chemicals Biosciences Moxifloxacin Related Compound F United States Pharmacopeia (USP) Reference Standard | 1179992-99-4 | 25MG | Sigma Aldrich Fine Chemicals Biosciences | ₹ 1,43,364.34 | |
 | Moxifloxacin Impurity 90; Usp Moxifloxacin Related Compound F | ChemScene | -- | |
 | 1179992-99-4 | Moxifloxacin Related Compound F (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | A2B Chem | ₹ 93,003.72 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Moxifloxacin Related Compound F USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.Also, for use with USP monograph such as Moxifloxacin Tablets
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P264 - P273 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: moxifloxacin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
grade:
pharmaceutical primary standard
API family:
moxifloxacin
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
grade: __
API family: __
manufacturer/tradename: __
application(s): __
format: __
grade:
__
API family:
__
manufacturer/tradename:
__
application(s):
__
format:
__
grade: pharmaceutical primary standard
API family: mupirocin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
grade:
pharmaceutical primary standard
API family:
mupirocin
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
grade: pharmaceutical primary standard
API family: mupirocin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
grade:
pharmaceutical primary standard
API family:
mupirocin
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat